Ujjal Kumar Mukherjee

521 total citations
32 papers, 347 citations indexed

About

Ujjal Kumar Mukherjee is a scholar working on Molecular Biology, Hematology and Strategy and Management. According to data from OpenAlex, Ujjal Kumar Mukherjee has authored 32 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Hematology and 5 papers in Strategy and Management. Recurrent topics in Ujjal Kumar Mukherjee's work include Multiple Myeloma Research and Treatments (6 papers), COVID-19 epidemiological studies (5 papers) and Protein Degradation and Inhibitors (5 papers). Ujjal Kumar Mukherjee is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), COVID-19 epidemiological studies (5 papers) and Protein Degradation and Inhibitors (5 papers). Ujjal Kumar Mukherjee collaborates with scholars based in United States, India and Netherlands. Ujjal Kumar Mukherjee's co-authors include Kingshuk K. Sinha, Amit Mitra, Shaji Kumar, Yixiang Wang, Michael J. Plewa, Vishal Verma, S. Vincent Rajkumar, Brian Van Ness, Jin Sung Jang and Jin Jen and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Ujjal Kumar Mukherjee

31 papers receiving 337 citations

Peers

Countries citing papers authored by Ujjal Kumar Mukherjee

Since Specialization

Citations

This map shows the geographic impact of Ujjal Kumar Mukherjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ujjal Kumar Mukherjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ujjal Kumar Mukherjee more than expected).

Fields of papers citing papers by Ujjal Kumar Mukherjee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ujjal Kumar Mukherjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ujjal Kumar Mukherjee. The network helps show where Ujjal Kumar Mukherjee may publish in the future.

Co-authorship network of co-authors of Ujjal Kumar Mukherjee

This figure shows the co-authorship network connecting the top 25 collaborators of Ujjal Kumar Mukherjee. A scholar is included among the top collaborators of Ujjal Kumar Mukherjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ujjal Kumar Mukherjee. Ujjal Kumar Mukherjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Encounter Decisions for Patients With Diverse Sociodemographic Characteristics: Predictive Analytics of EMR Data From a Large Chain of Clinics 2025 ·Journal of Operations Management ·Ujjal Kumar Mukherjee, Han Ye, Dilip Chhajed	1
2	Operations Management in the Pharmaceutical Industry 2025 ·Journal of Operations Management ·Gopesh Anand, George Ball, John Gray, Ujjal Kumar Mukherjee	1
3	Autism Ashram 2024 ·Emerald Emerging Markets Case Studies ·Ujjal Kumar Mukherjee	1
4	Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma 2023 ·Blood Cancer Journal ·Amit Mitra, Ujjal Kumar Mukherjee, (unknown), Vithal Madhira, Timothy Bergquist, Yu Raymond Shao, Feifan Liu, Qianqian Song, Jing Su, Shaji Kumar, Benjamin Bates, Noha Sharafeldin, Ümit Topaloĝlu, Christopher G. Chute, Richard A. Moffitt, Melissa Haendel	2
5	Single-Cell Multi-Ome Analysis Reveals Novel Molecular Mechanisms Underlying Subclonal Response to Survivin Inhibition in Relapsed/Refractory Multiple Myeloma 2023 ·Blood ·(unknown), (unknown), (unknown), Neeraj Sharma, (unknown), Ujjal Kumar Mukherjee, (unknown), Linda B. Baughn, Brian G. Van Ness, Amit Mitra	1
6	COVID-19 test-to-stay program for K-12 schools: Opt-in versus opt-out consent model 2023 ·iScience ·(unknown), Ujjal Kumar Mukherjee, Subhonmesh Bose, Sridhar Seshadri, Ronald D. Watkins, (unknown), (unknown), Mehmet Eren Ahsen, (unknown)	0
7	CEO Stock Ownership, Recall Timing, and Stock Market Penalties 2023 ·Manufacturing & Service Operations Management ·Jessica L. Darby, David J. Ketchen, George Ball, Ujjal Kumar Mukherjee	9
8	Detecting and mitigating simultaneous waves of COVID-19 infections 2022 ·Scientific Reports ·(unknown), (unknown), Subhonmesh Bose, (unknown), (unknown), Ujjal Kumar Mukherjee, Sridhar Seshadri	4
9	secDrug: a pipeline to discover novel drug combinations to kill drug-resistant multiple myeloma cells using a greedy set cover algorithm and single-cell multi-omics 2022 ·Blood Cancer Journal ·Harish Kumar, (unknown), (unknown), Neeraj Sharma, Ujjal Kumar Mukherjee, Shaji Kumar, Linda B. Baughn, Brian G. Van Ness, Amit Mitra	9
10	Integrating Pharmacogenomics Data-Driven Computational Drug Prediction with Single-Cell RNAseq to Demonstrate the Efficacy of a NAMPT Inhibitor against Aggressive, Taxane-Resistant, and Stem-like Cells in Lethal Prostate Cancer 2022 ·Cancers ·(unknown), (unknown), Ujjal Kumar Mukherjee, (unknown), (unknown), (unknown), (unknown), Panagiotis Mistriotis, (unknown), (unknown), (unknown), Windy Dean‐Colomb, Clayton Yates, Robert D. Arnold, Amit Mitra	9
11	Hiding in the Herd: The Product Recall Clustering Phenomenon 2021 ·Manufacturing & Service Operations Management ·Ujjal Kumar Mukherjee, George Ball, Kaitlin D. Wowak, (unknown), Jason Miller	21
12	A behavioral perspective on service center routing: The role of inertia 2021 ·Journal of Operations Management ·Aaron Schecter, Kaitlin D. Wowak, Nicholas Berente, Han Ye, Ujjal Kumar Mukherjee	6
13	Recommending encounters according to the sociodemographic characteristics of patient strata can reduce risks from type 2 diabetes 2021 ·PLoS ONE ·Han Ye, Ujjal Kumar Mukherjee, Dilip Chhajed, (unknown), (unknown)	2
14	Control Of Epidemic Spreads Via Testing And Lock-Down 2021 ·2021 60th IEEE Conference on Decision and Control (CDC) ·Subhonmesh Bose, (unknown), Ujjal Kumar Mukherjee, (unknown), Sridhar Seshadri, Albert C. England, (unknown)	1
15	Evaluation of reopening strategies for educational institutions during COVID-19 through agent based simulation 2021 ·Scientific Reports ·Ujjal Kumar Mukherjee, Subhonmesh Bose, (unknown), (unknown), Sridhar Seshadri, (unknown), (unknown), Yuqian Xu	27
16	Hotspots for Emerging Epidemics: Multi-Task and Transfer Learning over Mobility Networks 2021 ·SSRN Electronic Journal ·(unknown), Yuqian Xu, Ujjal Kumar Mukherjee, Sridhar Seshadri, Mehmet Eren Ahsen, (unknown), (unknown), (unknown), (unknown)	1
17	Explaining Heterogeneity in Environmental Management Practice Adoption across Firms 2019 ·Production and Operations Management ·(unknown), Rachna Shah, Ujjal Kumar Mukherjee	20
18	Assessing the cytotoxicity of ambient particulate matter (PM) using Chinese hamster ovary (CHO) cells and its relationship with the PM chemical composition and oxidative potential 2018 ·Atmospheric Environment ·Yixiang Wang, Michael J. Plewa, Ujjal Kumar Mukherjee, Vishal Verma	37
19	A gene expression signature distinguishes innate response and resistance to proteasome inhibitors in multiple myeloma 2017 ·Blood Cancer Journal ·Amit Mitra, (unknown), Ujjal Kumar Mukherjee, Jin Sung Jang, (unknown), (unknown), Jin Jen, Pieter Sonneveld, Shaji Kumar, W. Michael Kuehl, S. Vincent Rajkumar, Brian Van Ness	33
20	Fast algorithm for computing weighted projection quantiles and data depth for high-dimensional large data clouds 2014 ·Ujjal Kumar Mukherjee, Snigdhansu Chatterjee	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact